Urethral discharge evaluation and empiric treatment (male)
Suspected urethral infection presenting with white penile discharge should be managed as possible sexually transmitted urethritis until proven otherwise. [1] Empiric gonorrhea and chlamydia treatment should be provided when objective evidence of urethritis is present and when follow-up or test-based treatment is not assured. [1]
Urology hospitals and diagnostic centers in Bangladesh appropriate for this presentation
- National Institute of Kidney Disease and Urology (NIKDU), Dhaka (postgraduate institute & hospital under DGHS). [2]
- Bangladesh Specialized Hospital (Urology department), Dhaka. [3]
- Bangladesh Medical University (BMU) Urology department with access to BMU Super Specialized Hospital services in Dhaka. [4]
Initial investigations in suspected urethritis
- Detailed sexual and medical history including recent sexual exposure, condom use, prior STI treatment, dysuria severity, genital ulcers, and partner STI status. [1]
- Focused genital examination to assess for urethral discharge, meatal inflammation, genital ulcers, and concomitant scrotal pain suggestive of epididymitis/orchitis. [1]
- NAAT testing on a urethral swab or first-catch urine for Neisseria gonorrhoeae and Chlamydia trachomatis. [1]
- Microscopy of urethral discharge when available to support objective urethritis and guide whether empiric therapy should cover gonorrhea plus chlamydia versus chlamydia alone in low gonorrhea probability settings. [5]
- HIV and syphilis testing should be offered as part of STI evaluation. [6]
Empiric antibiotic treatment for suspected gonorrhea and chlamydia
Empiric therapy should cover gonorrhea and chlamydia when urethritis is likely and follow-up is not reliable. [1]
- Ceftriaxone 500 mg IM in a single dose plus doxycycline 100 mg orally twice daily for 7 days. [1]
Coverage for additional causes of non-gonococcal urethritis
Additional targeted testing and treatment for organisms beyond gonorrhea and chlamydia depend on local epidemiology and testing availability. [1]
- Trichomonas vaginalis testing and treatment should be pursued in settings where it is prevalent or when persistent/recurrent urethritis occurs with relevant risk. [1]
- Mycoplasma genitalium testing is recommended for persistent or recurrent NGU when available by NAAT. [1]
Partner management and counseling
- Sex partners should be referred for evaluation and treatment when an STI is diagnosed or when presumptive treatment is provided. [1]
- Abstinence from sex during treatment and until symptoms resolve should be advised to prevent reinfection. [1]
Treatment initiation thresholds and follow-up plan
- **Empiric treatment is recommended when objective urethritis is present and when follow-up or test results cannot be obtained promptly. [1]
- If symptoms persist after treatment, reassessment should include evaluation for treatment failure, reinfection, and alternative diagnoses. [1]
Common pitfalls to avoid
- Omission of NAAT for gonorrhea and chlamydia when available, which reduces the ability to confirm diagnosis and guide resistance-aware management on recurrence. [1]
- Delayed treatment when return follow-up is uncertain, which increases ongoing transmission risk and complicates partner management. [1]
- Failure to test for HIV and syphilis during STI workup, despite recommendations to offer these tests. [6]
Target goals of therapy
- Symptom resolution after treatment with appropriate empiric coverage is the primary short-term clinical goal. [1]
- Reduction in ongoing transmission through partner treatment and behavioral counseling is a key treatment goal. [1]